Related Experiment Video
Updated: Sep 15, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Cancer Vaccines: Mechanisms, Clinical Applications, Challenges, and Future Directions in Precision Medicine
Alaa A A Aljabali1, Omar Gammoh2, Mohammad Obeid1
1Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid, 21163, Jordan.
Abstract:
Cancer poses a major health burden worldwide, necessitating the development of novel therapeutic approaches. Personalized cancer vaccines represent a promising form of immunotherapy that enhances the ability of the immune system to recognize and destroy tumor cells through tumor-associated and cancer-specific antigens. This review categorizes cancer vaccines into preventive, therapeutic, and personalized vaccines, discussing their mechanisms, clinical applications, and current FDA-approved examples, such as Sip-uleucel-T and HPV vaccines. We highlight the recent advances in RNA-based vaccines, viral vectors, and nanotechnology, along with the synergistic role of cancer vaccines and immune checkpoint inhibitors in improving therapeutic efficacy. Overcoming ethical, regulatory, and technological barriers through global collaboration is essential for maximizing vaccine efficacy and enhancing patient outcomes. This review highlights the pivotal role of personalized vaccines in advancing precision medicine and reshaping cancer treatment paradigms.
Insights
Personalized cancer vaccines offer a promising immunotherapy approach to enhance the immune system's tumor-fighting capabilities. Advances in vaccine technology and combination therapies are crucial for improving cancer treatment outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Vaccinology
Background:
- Cancer represents a significant global health challenge, driving the need for innovative therapeutic strategies.
- Immunotherapy, particularly cancer vaccines, aims to harness the immune system to target and eliminate tumor cells.
- Tumor-associated antigens and cancer-specific antigens are key targets for vaccine development.
Purpose of the Study:
- To review and categorize different types of cancer vaccines, including preventive, therapeutic, and personalized approaches.
- To discuss the mechanisms of action, clinical applications, and existing FDA-approved cancer vaccines.
- To highlight recent technological advancements and synergistic treatment strategies in cancer vaccine development.
Main Methods:
- Literature review and synthesis of existing research on cancer vaccines.
- Categorization of vaccines based on their type and application.
- Discussion of emerging technologies like RNA-based vaccines, viral vectors, and nanotechnology.
- Analysis of combination therapies, including cancer vaccines and immune checkpoint inhibitors.
Main Results:
- Cancer vaccines are classified into preventive, therapeutic, and personalized types, each with distinct mechanisms and applications.
- FDA-approved examples like Sip-uleucel-T and HPV vaccines demonstrate clinical efficacy.
- Recent advances include RNA-based vaccines, viral vectors, and nanotechnology, enhancing vaccine potential.
- Synergistic use of cancer vaccines with immune checkpoint inhibitors shows promise for improved therapeutic outcomes.
Conclusions:
- Personalized cancer vaccines are pivotal in advancing precision medicine and transforming cancer treatment paradigms.
- Global collaboration is essential to address ethical, regulatory, and technological challenges for optimal vaccine efficacy.
- Continued research and development in cancer vaccines are critical for improving patient survival and quality of life.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microorganisms in Medicine and Therapeutics
Mechanisms of Retrovirus-induced Cancers
Cancer Prevention
Some...